Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
about
Lung cancer signatures in plasma based on proteome profiling of mouse tumor modelsOrigins, genetic landscape, and emerging therapies of small cell lung cancerActivation of the PI3K/mTOR Pathway following PARP Inhibition in Small Cell Lung CancerApplication of biclustering of gene expression data and gene set enrichment analysis methods to identify potentially disease causing nanomaterialsNfib Promotes Metastasis through a Widespread Increase in Chromatin Accessibility.Genetic requirement for Mycl and efficacy of RNA Pol I inhibition in mouse models of small cell lung cancerPTEN is a potent suppressor of small cell lung cancer.Differential expression analysis at the individual level reveals a lncRNA prognostic signature for lung adenocarcinoma.Small cell lung cancer: where do we go from here?Expression of a neuroendocrine gene signature in gastric tumor cells from CEA 424-SV40 large T antigen-transgenic mice depends on SV40 large T antigen.G1 arrest and differentiation can occur independently of Rb family function.Fuzzy tandem repeats containing p53 response elements may define species-specific p53 target genesInvolvement of aryl hydrocarbon receptor signaling in the development of small cell lung cancer induced by HPV E6/E7 oncoproteins.Xenobiotic-induced hepatocyte proliferation associated with constitutive active/androstane receptor (CAR) or peroxisome proliferator-activated receptor α (PPARα) is enhanced by pregnane X receptor (PXR) activation in mice.ATP-noncompetitive CDK inhibitors for cancer therapy: an overview.Small-cell lung cancer-associated autoantibodies: potential applications to cancer diagnosis, early detection, and therapy.High incidence of HPV-associated head and neck cancers in FA deficient mice is associated with E7's induction of DNA damage through its inactivation of pocket proteinsNuclear factor I/B is an oncogene in small cell lung cancerLung neuroendocrine tumors: correlation of ubiquitinylation and sumoylation with nucleo-cytosolic partitioning of PTEN.miR than meets the eye.Characterization of the cell of origin for small cell lung cancerSmall cell lung cancer: will recent progress lead to improved outcomes?The Evolutionarily Conserved C-terminal Domains in the Mammalian Retinoblastoma Tumor Suppressor Family Serve as Dual Regulators of Protein Stability and Transcriptional Potency.The comparative pathology of genetically engineered mouse models for neuroendocrine carcinomas of the lung.Ectopic expression of a small cell lung cancer transcription factor, INSM1 impairs alveologenesis in lung development.A crucial requirement for Hedgehog signaling in small cell lung cancerPerturbation of Rb, p53, and Brca1 or Brca2 cooperate in inducing metastatic serous epithelial ovarian cancerInactivating all three rb family pocket proteins is insufficient to initiate cervical cancer.Functional characterization of pulmonary neuroendocrine cells in lung development, injury, and tumorigenesis.Poly(β-amino ester) nanoparticle delivery of TP53 has activity against small cell lung cancer in vitro and in vivo.Comprehensive genomic profiles of small cell lung cancer.CD47-blocking immunotherapies stimulate macrophage-mediated destruction of small-cell lung cancer.Growth suppression by MYC inhibition in small cell lung cancer cells with TP53 and RB1 inactivation.A drug repositioning approach identifies tricyclic antidepressants as inhibitors of small cell lung cancer and other neuroendocrine tumors.High incidence of female reproductive tract cancers in FA-deficient HPV16-transgenic mice correlates with E7's induction of DNA damage response, an activity mediated by E7's inactivation of pocket proteins.Mouse models for lung cancerIntegrative genome analyses identify key somatic driver mutations of small-cell lung cancerOpening a Chromatin Gate to Metastasis.MYC Drives Progression of Small Cell Lung Cancer to a Variant Neuroendocrine Subtype with Vulnerability to Aurora Kinase Inhibition.Ablating all three retinoblastoma family members in mouse lung leads to neuroendocrine tumor formation.
P2860
Q24628852-B84C8D39-29AC-443E-ABC7-C0907694AE9CQ26798218-518CFEB5-FF1D-4885-899C-3C07A1F976DAQ27315948-8DDD26F5-CF2E-4EA1-B2ED-4CFFE672762CQ28385494-26142535-2EA5-4547-89F5-FF43F44A24D9Q30276428-133C31C8-38F9-476C-B534-3E945542B62BQ30276619-9F223DFC-706A-4F78-B5F9-FA2444592086Q33610833-177B08AB-6455-4FB6-80DD-8D785E7BC27EQ33771364-503AFA94-4E5B-4729-9A96-63AC106958A1Q33872327-894BE351-A2DE-4D6F-B1AC-870B44465223Q34130710-34C53E77-7368-4114-83BF-1BC614927B1EQ34317041-1FD31893-AC77-4DB4-8D49-AB2ACBC58B09Q34325529-D919EA58-3AC9-45BA-B504-8588357CB63FQ34499329-88483AA6-4B8A-4D33-A25E-8A157085F7A5Q34692352-B2B62EE9-E408-47A2-B8E8-BD263819BA39Q34756557-96502360-D79B-48DD-8C87-6F3859A65F61Q34826137-BBA39B88-0AA5-416D-89E6-4BB40B3E7A9FQ35005358-3C883D42-CACE-40BC-A049-16394A35ADF5Q35128800-0607918E-9593-4D69-B1DD-196B722D3739Q35151381-E6065398-CE98-48F0-9FE0-EED6AAE576D3Q35193208-6B25A56F-F900-4F29-97B5-8042E892EE9BQ35559970-5C911F63-2087-476B-831F-2B9DEA3D9820Q35836257-2B292C7C-D391-4A26-A7EF-561847759E57Q35860784-1D0CFD90-8411-483B-AC2D-F98688B3DEC6Q35911414-BE1E1F74-F006-418D-A43F-33B8CC68CE5BQ35987719-E10C80D4-C97F-491B-B61E-3770B64540FBQ36050816-8D8AC767-6ADE-44BE-83B3-EFA528F1BD66Q36170279-53F001AC-E106-415E-A8F4-AF833B57EC15Q36322847-47D9EA13-FBEC-466B-873D-4F3EBD077B54Q36378496-37D4C688-C8AA-474A-BA02-BCF82087F390Q36759358-69B56875-45ED-4A8A-B1BB-011AF8E16D0DQ36883530-C2A2E0B7-9396-4E0F-BB77-983E6AE8BDDAQ37042256-63E9CC4B-17DF-4292-9198-EB749C6BB2E7Q37327647-A4B970AF-7114-4459-82D6-42C6272518ADQ37395737-5B78C6EA-4F94-4C2B-BE65-9B32CE2B5EAFQ37722678-662E4EFC-25F5-434D-80DE-421DAB2995A0Q38088500-6E3E609C-1162-41F4-8201-E22EC69FB893Q38322114-F7CEE1D2-0249-4342-9679-C28FDE67B8D2Q38758025-A928D83C-56CF-4870-A8B5-D5BD0A2403F0Q39019412-6A38A01B-5138-4201-94C5-CF026785C373Q39102749-9287D88A-6D6C-4CC1-A771-DE7362658A9B
P2860
Loss of p130 accelerates tumor development in a mouse model for human small-cell lung carcinoma.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年論文
@yue
2010年論文
@zh-hant
2010年論文
@zh-hk
2010年論文
@zh-mo
2010年論文
@zh-tw
2010年论文
@wuu
2010年论文
@zh
2010年论文
@zh-cn
name
Loss of p130 accelerates tumor ...... man small-cell lung carcinoma.
@en
type
label
Loss of p130 accelerates tumor ...... man small-cell lung carcinoma.
@en
prefLabel
Loss of p130 accelerates tumor ...... man small-cell lung carcinoma.
@en
P2093
P2860
P1433
P1476
Loss of p130 accelerates tumor ...... man small-cell lung carcinoma.
@en
P2093
Anthony N Karnezis
Bethany E Schaffer
Chenwei Lin
Deborah L Burkhart
E Alejandro Sweet-Cordero
Gloria Yiu
Jamie F Conklin
Kwon-Sik Park
P2860
P304
P356
10.1158/0008-5472.CAN-09-4228
P407
P50
P577
2010-04-20T00:00:00Z